Designed to Meet the Needs of Female EVAR Patients

Addressing the unique anatomical needs of women with an Exceptional EVAR Stent Graft

Unique challenges face women in healthcare, including in AAA repair. Historically, women have been underserved by conventional EVAR. Only 34% of women with AAA (v. 54% of men) are eligible for EVAR treatment due to anatomical restrictions. Women need an exceptional EVAR treatment to meet their complex anatomical needs.

Explore ALTO Now

Endologix LLC is the legal manufacturer of the company's devices.

Prevalence of AAA

Higher for Men

54^%

Lower for Women

34^%

For every woman. For life. We remain focused.

Explore the clinical evidence of women treated with EVAR.

Download the Data

Disparities in EVAR among Women

Sonya Noor, MD, FACS See Dr. Sonya Noor's presentation, EVAR in complex female anatomy

Watch Video ▶

Exceptional EVAR Therapy

ALTO^® Stent Graft

We focused on and validated the Alto Stent Graft to meet the anatomical needs of women. Choose an EVAR treatment designed to meet the unique needs of the complex female anatomy.

CHALLENGE

SOLUTION

Excessive Aortic Neck Angulation

Exclusive adaptable sealing technology creates an effective seal around the vessel wall conforming to the patient’s native anatomy⁴

Short Proximal Neck Length

Separation of fixation and seal allows you to fixate graft in healthy tissue of the aorta and seal close to renals⁴

Smaller External Iliac Artery Diameter

Lowest profile device on the market: 13F inner diameter and 15F outer diameter⁵

What We Offer

Why Choose Rhevera?

Rhevera is committed to the steadfast pursuit of focused innovation, guided by data. Approach challenging anatomies with confidence and meet the unique needs of your complex patients. We strive to ally with physicians for procedural success and proficiency, including:

Virtual Reality (VR) Training

Build procedural confidence through immersive training.

Learn More →

Tailored Training

Access comprehensive product and therapy training designed around your team's needs.

Case Support

Rely on dedicated, expert field support throughout every procedure.

Peer Connection

Exchange insights through physician communities, roundtables, and peer-to-peer collaboration.

EVAR solution driven by data to meet the needs of complex female anatomy.

Explore Exceptional EVAR

Let’s Get Started

I would like to explore how I can treat my female patients with an exceptional stent graft

Rhevera Medical Holdings is the parent company of Endologix LLC. Endologix LLC is the legal manufacturer of the company's devices.

These are a portrayal of typical EVAR patients and not real patients.

REFERENCES

Ulug P, Sweeting MJ, von Allmen RS, Thompson ST, Powell JT. Lancet 2017; 389(10089):2482-2491.
Solberg et al. Eur J Vasc Endovasc Surg 2005; 29:145-149
Analysis based on available data from the LUCY Study female cohort (72 out of 76) and on comparisons with grafts ranging from 18F – 21F OD manufactured by global market leaders. Data extracted on May 1, 2017. The Ovation Abdominal Stent Graft System has not been studied in a head-to-head clinical study against other EVAR devices for outcomes in women.
Varkevisser et al. J Vasc Surg 2019
V.N. Tedjawirja, M.C.J. de Wit, R. Balm, M.J.W. Koelemay, Annals of Vascular Surgery, 2021: 76: 330-341

Legal Information:

INDICATIONS FOR USE:
The ALTO^® Abdominal Stent Graft System is indicated for treatment of patients with infrarenal abdominal aortic aneurysms having the vascular morphology suitable
for endovascular repair with the device, which includes the following:

Adequate iliac/femoral access compatible with vascular access techniques (femoral cutdown or percutaneous), devices, and/or accessories,
A proximal aortic landing zone for the sealing ring 7 mm below the inferior renal artery.
An aortic sealing zone comprised of healthy aorta defined as:
- Lack of significant thrombus > 8 mm in thickness; at any point along the aortic circumference at the level of 7mm below the inferior renal artery,
- Lack of significant calcification at the level of 7 mm below the inferior renal artery,
- Conicity < 10% as measured from the inferior renal artery to the aorta 7 mm below the inferior renal artery,
- An inner wall diameter of no less than 16 mm and no greater than 30 mm at 7 mm below the inferior renal artery, and
- An aortic angle of ≤ 60 degrees
A distal iliac landing zone:
- With a length of at least 10 mm, and
- With an inner wall diameter of no less than 8 mm and no greater than 25 mm.

CONTRAINDICATIONS: The system is contraindicated for use in patients who have a condition that threatens to infect the graft and in patients with known sensitivities or allergies to the
device materials including polytetrafluoroethylene [PTFE], polyethylene glycol [PEG]-based polymers, contrast agents, fluorinated ethylene propylene [FEP], titanium, nickel, platinum, or iridium.

Refer to Instructions for Use for more information concerning Indications, Contraindications, Specific Anatomic Considerations, Warnings, Precautions, and Adverse Events.

CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician.

NOTE: Not all product components are available in every country. Please consult with your Endologix representative to confirm product availability.

Endologix is a registered trademark of Endologix LLC in the United States, Europe and Japan, and Rhevera, Rhevera Medical, the Rhevera logo, ALTO, AFX, Detour and Pounce are trademarks of Endologix LLC and its subsidiaries. All other trademarks are the property of their respective owners.